Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-23-000009

Chief Financial Officer acquired 79,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HASTINGS DAVID C · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-01 Grant or award : show line 1 in the form +79,000 79,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +316,000 316,000 D
Loading xslF345X03/wf-form4_167545863617086.xml…